Beta 2-microglobulin deposition in bone in chronic renal failure

Area of Science:

• Nephrology
• Orthopedic Surgery
• Pathology

Background:

• Beta 2 microglobulin (beta 2 m) amyloidosis is increasingly reported in soft tissues of dialysis patients.
• Bone involvement of beta 2 m amyloid deposition is less understood.
• Long-term hemodialysis is a risk factor for amyloid accumulation.

Purpose of the Study:

• To determine the prevalence of beta 2 m deposition in bone biopsies from hemodialysis patients.
• To assess the relationship between beta 2 m deposits and bone histomorphometry.
• To investigate the association between bone beta 2 m deposition and fracture risk.

Main Methods:

• Analysis of bone biopsy specimens from 224 patients undergoing long-term hemodialysis.
• Immunohistochemical staining for beta 2 m deposition.
• Histomorphometric analysis of bone structure.
• Comparison of fracture incidence in patients with and without beta 2 m deposition.

Main Results:

• Beta 2 m deposits were found in 8% of patients, increasing to 19% in those on dialysis for over 10 years.
• Deposition was observed in various bone sites, notably the iliac crest periosteum.
• Patients with iliac crest beta 2 m deposition had a significantly higher rate of femoral neck fractures (62% vs 4%).
• Osteitis fibrosa appeared more common in patients with beta 2 m deposits.

Conclusions:

• Beta 2 m deposition in bone is a frequent finding in uremic patients with over 10 years of hemodialysis.
• Periosteal beta 2 m deposition in the iliac crest may predict susceptibility to femoral fractures.
• Further research is warranted to understand the mechanism linking beta 2 m deposition to bone fragility and fractures.